Stephens & Co. Reiterates Overweight on Encompass Health, Maintains $78 Price Target
Portfolio Pulse from richadhand@benzinga.com
Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on Encompass Health (NYSE:EHC) and maintained a price target of $78.
July 20, 2023 | 1:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Encompass Health's stock rating has been reiterated as Overweight by Stephens & Co. with a maintained price target of $78.
The reiteration of an Overweight rating indicates that the analyst believes the company's stock will outperform the market in the near future. This, coupled with the maintained price target, suggests a positive outlook for Encompass Health's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100